Aptose Biosciences Inc. (APTO)
NASDAQ: APTO
· Real-Time Price · USD
1.71
0.00 (0.00%)
At close: Apr 01, 2025, 3:59 PM
Aptose Biosciences Cash Flow Statement
Financials in USD. Fiscal
year is
January - December.
| Fiscal Year | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 | Q2 2022 | Q1 2022 | Q4 2021 | Q3 2021 | Q2 2021 | Q1 2021 |
| Period Ending | Mar 31, 2025 | Dec 31, 2024 | Sep 30, 2024 | Jun 30, 2024 | Mar 31, 2024 | Dec 31, 2023 | Sep 30, 2023 | Jun 30, 2023 | Mar 31, 2023 | Dec 31, 2022 | Sep 30, 2022 | Jun 30, 2022 | Mar 31, 2022 | Dec 31, 2021 | Sep 30, 2021 | Jun 30, 2021 | Mar 31, 2021 |
Net Income | -5.54M | -1.58M | -6.95M | -7.25M | -9.64M | -11.96M | -11.45M | -14.13M | -13.68M | -10M | -9.78M | -10.56M | -11.48M | -24.32M | -11.33M | -13.47M | -16.23M |
Depreciation & Amortization | 99K | 97K | 96K | 102K | 108.51K | 110K | 111K | 114K | 131K | 100K | 141K | 141K | 146K | 163K | 155K | 152K | 152K |
Stock-Based Compensation | 326K | 57K | -13K | 207K | 809K | 411K | 599K | 769K | 1.87M | 861K | 1.05M | 779K | 2.51M | 2.31M | 1.83M | 2.16M | 6.64M |
Other Working Capital | 1.15M | -4.94M | 1.76M | -3.6M | 560.75K | -1.1M | 913K | 1.7M | 1.16M | -2.85M | 1.49M | 1.28M | -267K | -1.62M | 2.56M | 1.15M | -256.07K |
Other Non-Cash Items | 43K | -1.11M | 15K | 76K | 23.74K | -204.17K | -22K | 60K | 16K | -667K | 89K | 64.43K | -2K | 7.35M | 11K | -128K | -124.93K |
Deferred Income Tax | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Change in Working Capital | 2.28M | -5.51M | -3.52M | 1.09M | -3.06M | 2.14M | 223K | -317K | 353K | 1.05M | 1.51M | 2.53M | -822K | -1.55M | 1.28M | 2.46M | -819.07K |
Operating Cash Flow | -2.79M | -8.06M | -10.38M | -5.78M | -11.76M | -9.5M | -10.54M | -13.5M | -11.3M | -8.65M | -6.98M | -7.05M | -9.64M | -16.04M | -8.06M | -8.82M | -10.38M |
Capital Expenditures | n/a | -6K | n/a | n/a | 1K | -60.97 | n/a | -29K | n/a | n/a | n/a | -24K | n/a | -14K | -181K | n/a | -17K |
Cash Acquisitions | n/a | n/a | n/a | n/a | 995.53 | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Purchase of Investments | n/a | n/a | n/a | n/a | n/a | n/a | n/a | -1.93M | -2.96M | n/a | n/a | n/a | n/a | -19.81M | -4K | n/a | -20M |
Sales Maturities Of Investments | n/a | n/a | n/a | n/a | n/a | 1.93M | 12.95M | n/a | n/a | 12.49M | n/a | 10.09M | 7.5M | n/a | n/a | 5M | n/a |
Other Investing Acitivies | n/a | n/a | n/a | 2.01M | -1.99M | 63.41K | n/a | n/a | n/a | 5.08M | -5.08M | n/a | n/a | -184.53K | n/a | n/a | n/a |
Investing Cash Flow | n/a | -7K | n/a | 2.01M | -1.99M | 1.99M | 12.95M | -1.96M | -2.96M | 17.57M | -5.08M | 10.07M | 7.5M | -20.01M | -185K | 5M | -20.01M |
Debt Repayment | n/a | n/a | 10M | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Common Stock Repurchased | 1K | 26K | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Dividend Paid | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Other Financial Acitivies | 1K | 179K | 8K | -177K | 52.92K | 10K | 58K | -5K | 16K | 1.12K | n/a | 303.00 | 15K | 30K | n/a | 85K | 75K |
Financial Cash Flow | 829K | 6.8M | 10.01M | 4.75M | 11.85M | 854K | 4.9M | 1.1M | 50K | 51K | 21K | 29K | 15K | 66K | n/a | 85K | 75K |
Net Cash Flow | -1.96M | -1.25M | -368K | 984K | -1.91M | -6.47M | 7.32M | -14.36M | -14.21M | 8.98M | -12.04M | 3.04M | -2.12M | -35.98M | -8.25M | -3.74M | -30.31M |
Free Cash Flow | -2.79M | -8.06M | -10.38M | -5.78M | -11.71M | -9.26M | -10.54M | -13.53M | -11.3M | -8.65M | -6.98M | -7.07M | -9.64M | -16.06M | -8.24M | -8.82M | -10.39M |